RemedyMeds
eDR61Effective DR: 61/100. Below median. Measured by StartupHub.ai. Median 68.Agent40Agent Readiness: 40/100. Below median. Measured by StartupHub.ai. Median 41.The easiest weight loss method ever - delivered to your door.
About
Remedy Meds is an online consumer health and pharmacy platform that provides access to compounded glucagon-like peptide-one receptor agonist (GLP-1) medications, such as semaglutide and tirzepatide, for weight loss. The platform offers unlimited video calls and messaging with clinicians and a monthly supply of medication, aiming to support individuals in the U.S. with their weight loss journey.
Key facts
At-a-glance profile data
- Website
- remedymeds.com
- Headquarters
- Summit, United States
- Founded
- 2024
- Total funding
- $23M (Series A)
- Business model
- B2C
Tech stack
Detected on remedymeds.com, last scanned 20 Aug 2026. Run your own scan
- Frontend
- Next.js, Tailwind CSS
- CDN
- Vercel
- Email provider
- Google Workspace
Frequently asked
What does RemedyMeds do?
The company emphasizes ease of onboarding, platform usability, and a straightforward cancellation process.
What is RemedyMeds's Effective Domain Rating?
StartupHub's Effective Domain Rating for RemedyMeds is 61 out of 100, measuring real cross-surface visibility in search engines and AI answers rather than claimed link authority. That is underrated against its Ahrefs Domain Rating of 46, meaning it surfaces in search and AI results more than its claimed authority alone would suggest.
Is RemedyMeds trustworthy and reputable?
StartupHub's Data Trust & Reputation score for RemedyMeds is 60 out of 100, based on site security posture and privacy practices.
How much funding has RemedyMeds raised?
RemedyMeds has raised a total of $23M in funding. The most recent round on record is Series A.